Stock Analysis

Spotlight On ASX: 3 Penny Stocks With Market Caps Over A$100M

ASX:ALK
Source: Shutterstock

Over the last 7 days, the Australian market has risen 1.5%, and over the past year, it is up 17%, with earnings forecasted to grow by 12% annually. In light of these positive conditions, investors may find value in exploring penny stocks—an outdated term that still signifies smaller or less-established companies with potential for growth. By focusing on those with strong financials and clear growth trajectories, investors can uncover opportunities that offer both stability and upside potential.

Top 10 Penny Stocks In Australia

NameShare PriceMarket CapFinancial Health Rating
LaserBond (ASX:LBL)A$0.59A$69.16M★★★★★★
Embark Early Education (ASX:EVO)A$0.81A$148.62M★★★★☆☆
Helloworld Travel (ASX:HLO)A$2.00A$325.64M★★★★★★
SHAPE Australia (ASX:SHA)A$2.88A$238.78M★★★★★★
Austin Engineering (ASX:ANG)A$0.54A$334.88M★★★★★☆
MaxiPARTS (ASX:MXI)A$1.89A$104.55M★★★★★★
Navigator Global Investments (ASX:NGI)A$1.65A$808.63M★★★★★☆
GTN (ASX:GTN)A$0.4475A$87.7M★★★★★★
Atlas Pearls (ASX:ATP)A$0.15A$65.35M★★★★★★
Servcorp (ASX:SRV)A$4.80A$473.59M★★★★☆☆

Click here to see the full list of 1,046 stocks from our ASX Penny Stocks screener.

We'll examine a selection from our screener results.

Alkane Resources (ASX:ALK)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Alkane Resources Ltd is an Australian company focused on gold exploration and production, with a market cap of A$302.53 million.

Operations: The company generates revenue primarily from its Gold Operations segment, which accounts for A$173.58 million.

Market Cap: A$302.53M

Alkane Resources, with a market cap of A$302.53 million, primarily generates revenue from its Gold Operations segment, reporting A$173.58 million in sales for the last fiscal year. Despite seasoned management and board members, Alkane faces challenges with declining earnings growth of -58.4% over the past year and reduced profit margins from 22.3% to 10.2%. However, it remains debt-free, alleviating concerns about interest coverage and long-term liabilities despite short-term assets not fully covering long-term obligations. The company's stock trades significantly below estimated fair value but exhibits stable weekly volatility at 7%.

ASX:ALK Debt to Equity History and Analysis as at Nov 2024
ASX:ALK Debt to Equity History and Analysis as at Nov 2024

Emerald Resources (ASX:EMR)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Emerald Resources NL is involved in the exploration and development of mineral reserves in Cambodia and Australia, with a market cap of A$2.41 billion.

Operations: The company generates revenue primarily from its Mine Operations segment, which accounts for A$366.04 million.

Market Cap: A$2.41B

Emerald Resources, with a market cap of A$2.41 billion, has shown strong earnings growth, increasing by 41.9% over the past year and surpassing industry averages. The company maintains high-quality earnings and robust profit margins at 22.6%, up from the previous year. Its financial health is solid with short-term assets exceeding liabilities and debt well-covered by operating cash flow. However, shareholder dilution occurred recently with shares outstanding growing by 5.5%. Recent board changes include the retirement of Simon Lee AO, a key figure in Emerald's development into a gold producer in Cambodia and Australia.

ASX:EMR Financial Position Analysis as at Nov 2024
ASX:EMR Financial Position Analysis as at Nov 2024

Image Resources (ASX:IMA)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Image Resources NL is a mineral sands mining company based in Western Australia with a market capitalization of A$105.48 million.

Operations: Image Resources NL has not reported any specific revenue segments.

Market Cap: A$105.48M

Image Resources, with a market cap of A$105.48 million, is currently pre-revenue and unprofitable, facing increasing losses over the past five years at an annual rate of 33.2%. Despite this, the company benefits from being debt-free and having a seasoned management team with an average tenure of 9.3 years. Short-term assets (A$43.8M) exceed short-term liabilities (A$4.1M), but long-term liabilities remain uncovered by these assets (A$51.5M). Recent financial results show a net loss of A$5.16 million for the half-year ending June 2024, marking a decline from net income in the previous year.

ASX:IMA Financial Position Analysis as at Nov 2024
ASX:IMA Financial Position Analysis as at Nov 2024

Where To Now?

  • Click this link to deep-dive into the 1,046 companies within our ASX Penny Stocks screener.
  • Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments.
  • Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free.

Ready To Venture Into Other Investment Styles?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About ASX:ALK

Alkane Resources

Operates as a gold exploration and production company in Australia.

High growth potential with excellent balance sheet.

Community Narratives

AstraZeneca's Oncology and Obesity Innovations Will Drive Revenue Growth by 10%
Fair Value SEK 2.55k|37.875% undervalued
Unike
Unike
Community Contributor
Leading the Charge in SME SaaS Innovation
Fair Value SEK 100.02|24.815% undervalued
Investingwilly
Investingwilly
Community Contributor
Brookfield Corporation is a solid BUY for a long-term portfolio
Fair Value CA$82.23|4.8887% overvalued
Jonataninho
Jonataninho
Community Contributor